XT
MENS

XTX Topco’s Jyong Biotech MENS Stock Holding History

XTX Topco’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2K Buy
+29,066
New +$61.7K ﹤0.01% 3675

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's MENS Position: Q2 2026 in Review

XTX Topco opened a new position in Jyong Biotech (MENS) in Q2 2026: 29,066 shares worth $60.2K. The stake represents ﹤0.01% of the portfolio and ranks #3675 among its holdings.

19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • XTX Topco held 29,066 shares of Jyong Biotech worth $60.2K as of Q2 2026.
  • Jyong Biotech was a new XTX Topco position in Q2 2026.
  • Jyong Biotech made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3675 holding.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.